Company Filing History:
Years Active: 2024
Title: David Escors Murugarren: Innovator in Therapeutic Molecules
Introduction
David Escors Murugarren is a prominent inventor based in Pamplona, Spain. He has made significant contributions to the field of therapeutic molecules, particularly in the development of agents that target LAG-3 and PD-1. His innovative work aims to enhance treatment options for various diseases.
Latest Patents
David holds a patent for therapeutic molecules that bind to LAG3 and PD1. This invention relates to LAG-3 binding agents, specifically variable heavy chain (V) sdAbs and bispecific agents that target both LAG-3 and PD-1. The use of these binding agents is intended for the treatment, prevention, and detection of diseases.
Career Highlights
David is currently associated with Crescendo Biologics Limited, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective therapeutic solutions.
Collaborations
David collaborates with notable colleagues, including Carolyn Edwards and Angelica Sette. Their combined expertise contributes to the innovative environment at Crescendo Biologics Limited.
Conclusion
David Escors Murugarren is a key figure in the field of therapeutic innovations, with a focus on LAG-3 and PD-1 binding agents. His contributions are shaping the future of disease treatment and detection.